SoftBank Vision Fund 2 led a $100m Series D round in SprintRay.

Financials

Edit Data

Transaction Value£90m

Consideration TypeCash

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

bidder

Zwc Partners

bidder

Marathon Venture Partners

bidder

Softbank Vision Fund 2

bidder

Cd Capital Asset Management

target

SPRINTRAY

bidder

Yiheng Capital

Sources

Edit

Tags

Edit

dental care

Single Bidder

medical devices

Private

Completed

Medical Supplies

Friendly

3d printing

China

Private Equity

Acquisition

Cross Border

Minority

Venture Capital

Synopsis

Edit

SoftBank Vision Fund 2 led a $100m Series D round in SprintRay, a Chinese provider of dental-care solutions based on 3D printing, with participation from Yiheng Capital, ZWC Partners, CD Capital and Marathon Venture Partners. SprintRay looks to expand its global operations beyond the US and Europe.